Literature DB >> 19664921

Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives.

Tao Wang1, John F Kadow, Zhongxing Zhang, Zhiwei Yin, Qi Gao, Dedong Wu, Dawn DiGiugno Parker, Zheng Yang, Lisa Zadjura, Brett A Robinson, Yi-Fei Gong, Timothy P Spicer, Wade S Blair, Pei-Yong Shi, Gregory Yamanaka, Pin-Fang Lin, Nicholas A Meanwell.   

Abstract

4-Fluoro- and 4-methoxy-1-(4-benzoylpiperazin-1-yl)-2-(1H-indol-3-yl)ethane-1,2-dione (2 and 3, respectively) have been characterized as potent inhibitors of HIV-1 attachment that interfere with the interaction of viral gp120 with the host cell receptor CD4. As part of an effort to understand fundamental aspects of this pharmacophore, discovered originally using a high throughput cell-based screen, modification and substitution of the piperazine ring was examined in the context of compounds 6a-ah. The piperazine ring was shown to be a critical element of the HIV-1 attachment inhibiting pharmacophore, acting as a scaffold to deploy the indole glyoxamide and benzamide in a topographical relationship that complements the binding site on gp120.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19664921     DOI: 10.1016/j.bmcl.2009.07.076

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  Discovery of 2,6-Dimethylpiperazines as Allosteric Inhibitors of CPS1.

Authors:  Alan Rolfe; Shihua Yao; Toung-Vi Nguyen; Kiyoyuki Omoto; Federico Colombo; Milena Virrankoski; Frédéric H Vaillancourt; Lihua Yu; Andrew Cook; Dominic Reynolds; Stephanos Ioannidis; Ping Zhu; Nicholas A Larsen; David M Bolduc
Journal:  ACS Med Chem Lett       Date:  2020-05-26       Impact factor: 4.345

Review 2.  Thermodynamics-based drug design: strategies for inhibiting protein-protein interactions.

Authors:  Arne Schön; Sonia Y Lam; Ernesto Freire
Journal:  Future Med Chem       Date:  2011-07       Impact factor: 3.808

3.  Illuminating HIV gp120-Ligand Recognition through Computationally-Driven Optimization of Antibody-Recruiting Molecules.

Authors:  Christopher G Parker; Markus K Dahlgren; Ran N Tao; Don T Li; Eugene F Douglass; Takuji Shoda; Navneet Jawanda; Krasimir A Spasov; Sangil Lee; Nannan Zhou; Robert A Domaoal; Richard E Sutton; Karen S Anderson; William L Jorgensen; Mark Krystal; David A Spiegel
Journal:  Chem Sci       Date:  2014-06-01       Impact factor: 9.825

4.  Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120.

Authors:  Radhika Vangala; Sree Kanth Sivan; Saikiran Reddy Peddi; Vijjulatha Manga
Journal:  J Comput Aided Mol Des       Date:  2019-12-02       Impact factor: 3.686

5.  Chemically Programmed Antibodies AS HIV-1 Attachment Inhibitors.

Authors:  Shinichi Sato; Tsubasa Inokuma; Nobumasa Otsubo; Dennis R Burton; Carlos F Barbas
Journal:  ACS Med Chem Lett       Date:  2013-05-09       Impact factor: 4.345

6.  Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action.

Authors:  David R Langley; S Roy Kimura; Prasanna Sivaprakasam; Nannan Zhou; Ira Dicker; Brian McAuliffe; Tao Wang; John F Kadow; Nicholas A Meanwell; Mark Krystal
Journal:  Proteins       Date:  2014-12-23

7.  Synthesis and characterization of piperazine-substituted dihydrofuran derivatives viaMn(OAc) 3 mediated radical cyclizations.

Authors:  Sait Sari; Mehmet Yilmaz
Journal:  Turk J Chem       Date:  2020-10-26       Impact factor: 1.239

Review 8.  Innovation in the discovery of the HIV-1 attachment inhibitor temsavir and its phosphonooxymethyl prodrug fostemsavir.

Authors:  Tao Wang; John F Kadow; Nicholas A Meanwell
Journal:  Med Chem Res       Date:  2021-09-28       Impact factor: 1.965

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.